247 related articles for article (PubMed ID: 1851858)
1. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia.
Young LS; Lau R; Rowe M; Niedobitek G; Packham G; Shanahan F; Rowe DT; Greenspan D; Greenspan JS; Rickinson AB; Farrell PJ
J Virol; 1991 Jun; 65(6):2868-74. PubMed ID: 1851858
[TBL] [Abstract][Full Text] [Related]
2. Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia.
Becker J; Leser U; Marschall M; Langford A; Jilg W; Gelderblom H; Reichart P; Wolf H
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8332-6. PubMed ID: 1656439
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia.
Sandvej K; Krenács L; Hamilton-Dutoit SJ; Rindum JL; Pindborg JJ; Pallesen G
Histopathology; 1992 May; 20(5):387-95. PubMed ID: 1316871
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.
Niedobitek G; Young LS; Lau R; Brooks L; Greenspan D; Greenspan JS; Rickinson AB
J Gen Virol; 1991 Dec; 72 ( Pt 12)():3035-46. PubMed ID: 1662695
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.
Brousset P; Drouet E; Schlaifer D; Icart J; Payen C; Meggetto F; Marchou B; Massip P; Delsol G
AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
7. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
[TBL] [Abstract][Full Text] [Related]
8. Strain variation in Epstein-Barr virus immediate early genes.
Packham G; Brimmell M; Cook D; Sinclair AJ; Farrell PJ
Virology; 1993 Feb; 192(2):541-50. PubMed ID: 8093650
[TBL] [Abstract][Full Text] [Related]
9. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.
Greenspan JS; Greenspan D; Lennette ET; Abrams DI; Conant MA; Petersen V; Freese UK
N Engl J Med; 1985 Dec; 313(25):1564-71. PubMed ID: 2999595
[TBL] [Abstract][Full Text] [Related]
10. Histone acetylation and reactivation of Epstein-Barr virus from latency.
Jenkins PJ; Binné UK; Farrell PJ
J Virol; 2000 Jan; 74(2):710-20. PubMed ID: 10623733
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
13. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
Li Y; Webster-Cyriaque J; Tomlinson CC; Yohe M; Kenney S
J Virol; 2004 Apr; 78(8):4197-206. PubMed ID: 15047835
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.
Prang N; Wolf H; Schwarzmann F
J Virol; 1995 Apr; 69(4):2644-8. PubMed ID: 7884918
[TBL] [Abstract][Full Text] [Related]
16. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
Jung YJ; Choi H; Kim H; Lee SK
J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.
Speck SH; Chatila T; Flemington E
Trends Microbiol; 1997 Oct; 5(10):399-405. PubMed ID: 9351176
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.
Shimizu N; Takada K
J Virol; 1993 Jun; 67(6):3240-5. PubMed ID: 8388498
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]